enVVeno Medical Corp Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances
enVVeno Medical Corp (NVNO) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances of $1.94 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues · last filed 2019-03-14
- enVVeno Medical Corp fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2018-12-31 was $0.00.
- enVVeno Medical Corp fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2018-09-30 was $0.00.
- enVVeno Medical Corp fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2018 was $1.94M, a 53.16% increase from fiscal 2017.
- enVVeno Medical Corp fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2017 was $1.27M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $0.00 derived: sum of 2 quarters · filed 2019-03-14 | $1.94M 10-K · filed 2019-03-14 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $1.94M 10-Q · filed 2018-11-07 | ||
| 2018-06-30 | $1.94M 10-Q · filed 2018-08-10 | |||
| 2017-12-31 | $1.27M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |